rxstatShortages › Mometasone Furoate

Mometasone Furoate shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Mometasone Furoate products are in shortage in Canada (3 of 15 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 7, 2026.
Products affected
3 / 15
In shortage since
Feb 12, 2025
Est. full return
Aug 7, 2026
Reports on file
108
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-MOMETASONE
50MCG · SPRAY, METERED DOSE · APOTEX INC
DIN 02403587 · since Apr 21, 2026, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
ASMANEX TWISTHALER
100MCG · POWDER · ORGANON CANADA INC.
DIN 02438690 · since May 26, 2026, est. end Aug 7, 2026 · Delay in shipping of the drug.
Active shortage
TEVA-MOMETASONE
50MCG · SPRAY, METERED DOSE · TEVA CANADA LIMITED
DIN 02475863 · since Feb 12, 2025, no end estimate · Disruption of the manufacture of the drug.
To be discontinued
ELOCOM
0.1% · LOTION · ORGANON CANADA INC.
DIN 00871095
Resolved
TARO-MOMETASONE CREAM
0.1% · CREAM · TARO PHARMACEUTICALS INC
DIN 02367157 · ended May 21, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-MOMETASONE LOTION
0.1% · LOTION · TARO PHARMACEUTICALS INC
DIN 02266385 · ended Mar 26, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-MOMETASONE LOTION
0.1% · LOTION · TARO PHARMACEUTICALS INC
DIN 02266385 · ended Mar 26, 2026 · Disruption of the manufacture of the drug.
Resolved
ASMANEX TWISTHALER
100MCG · POWDER · ORGANON CANADA INC.
DIN 02438690 · ended Aug 27, 2025 · Delay in shipping of the drug.
Resolved
ASMANEX TWISTHALER
400MCG · POWDER · ORGANON CANADA INC.
DIN 02243596 · ended Aug 15, 2025 · Delay in shipping of the drug.
Resolved
TEVA-MOMETASONE
0.1% · OINTMENT · TEVA CANADA LIMITED
DIN 02248130 · ended Mar 26, 2025 · Disruption of the manufacture of the drug.
Resolved
ELOCOM
0.1% · OINTMENT · ORGANON CANADA INC.
DIN 00851736 · ended Feb 20, 2025 · Delay in shipping of the drug.
Resolved
ASMANEX TWISTHALER
200MCG · POWDER · ORGANON CANADA INC.
DIN 02243595 · ended Jan 29, 2025 · Delay in shipping of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Mometasone Furoate is currently affected by 3 active shortage reports filed with Health Canada by APOTEX INC, ORGANON CANADA INC., TEVA CANADA LIMITED.

The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Mometasone Furoate is classified under “OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS” (ATC R03BA).

Recent changes

Common questions

When will Mometasone Furoate be back in stock in Canada?

The latest manufacturer estimate is Aug 7, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Mometasone Furoate in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (other drugs for obstructive airway diseases, inhalants)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.